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Abstract 
BACKGROUND: Diabetes mellitus (DM) is a major risk factor for heart failure (HF) and coronary artery disease 
(CAD). DM may cause structural changes involving the left ventricle (LV) systolic and diastolic function. 
AIM: To compare patients who have diabetes and ischemic cardiomyopathy (ICM) to those with diabetic 
cardiomyopathy (DMCMP) regarding LV systolic function, diastolic function, in hospital long term and short-term 
mortality. 
METHODS: Ninety diabetic patients with heart failure and left ventricular ejection fraction (LVEF) ≤ 35%, admitted 
to Critical Care Medicine department Cairo University were divided into two groups based on coronary 
angiography results; group I (ICM) n = 48 patients and group II (DMCMP) n = 42 patients.  
RESULTS: Group I patients had higher mean age (63 ± 7 years), (p = 0.004), Hypertension (p ˂ 0.001) and 
dyslipidemia (p = 0.008) were significantly more present in group I compared to group II. No significant differences 
were found regarding LVEF, global longitudinal strain (GLS), E/A and E/É ratio in both groups. A significant 
difference in the wall motion score index (WMSI) in group I; (1.4 ± 0.4) versus group II; (1.1 ± 0.2), (p = 0.005) 
was found. In the study, 6 patients had a cardiogenic shock with no documented in-hospital mortality. At 6 
months, statistically, significantly higher mortality rates were found in group I, (p = 0.006), while at one year there 
was no significant difference in the mortality between the two groups, (p = 0.077). In comparison of the survived 
and non-survived patients at 6 months and one year in group I (ICM) there was a significant difference in LVEF 
(40 ± 6% vs 23 ± 6%, p ˂ 0.001), GLS (- 8.1 ± 2.4 vs - 4.6 ± 2.6, p = 0.007), E/A (1.25 ± 0.91 vs 1.8 ± 0.5, p = 
0.038), E/É (11.68 ± 7.5 vs 21.3 ± 3.6, p = 0.001) respectively. In group ll (DMCMP) there was no documented 
mortality at 6 months follow up, however, at one year there was statistically significant difference in the mortality 
between survived and non-survived patients; the LVEF (35 ± 8% vs 25 ± 2%, p = 0.014), GLS (-7.9 ± 2.9% vs -5 ± 
0.1%, p = 0.032), E/A (1.45 ± 0.8 vs 3.3 ± 0, p = 0.006) respectively. The E/É ratio in group ll was not significantly 
different between the groups (15.73 ± 5.3 vs 15 ± 1, p = 0.873). 
CONCLUSION: The combination of cardiomyopathy and diabetes affects LV systolic and diastolic function; 
however; ischemic cardiomyopathy and diabetic cardiomyopathy had a similar systolic and diastolic function. 
Ischemic cardiomyopathy is associated with worse prognosis compared to diabetic cardiomyopathy. 
 
 
 
 
 
 
Introduction 
 
Diabetes mellitus (DM) is a major risk factor 
for cardiovascular diseases, including coronary artery 
disease (CAD), congestive heart failure (CHF) and 
atrial fibrillation [1].
 
DM is associated with increased 
risk of cardiovascular-related deaths. Diabetes can 
lead to heart failure not only by augmenting coronary 
artery disease through macroangiopathy but also 
through structural changes involving the left ventricle 
(LV) causing systolic and diastolic dysfunction [2].  
We aimed to compare diabetic patients, who 
have ischemic cardiomyopathy (ICM) to those with 
diabetic cardiomyopathy (DMCMP) in terms of clinical 
course, left ventricular (LV) systolic function, diastolic 
function, in-hospital long and short-term mortality. 
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Methods 
 
Our study included 90 diabetic patients with 
decompensated heart failure due to cardiomyopathy 
with LVEF ≤ 35% admitted to Critical Care Medicine 
department over 16 months (March 2016- July 2017). 
Excluded from the study were patients with valvular 
heart disease, patients with diastolic heart failure and 
those with poor echocardiography window. The study 
was approved by the ethical committee at the faculty 
of medicine at Cairo University. Written consent was 
taken from all patients on admission. 
Complete disease history was performed for 
all patients, analysis of risk factors of coronary artery 
disease (CAD) and heart failure such as arterial 
hypertension, dyslipidemia, smoking and family 
history of CAD; detailed physical examination with 
special emphasis on Killip classification; coronary 
angiography to differentiate ischemic from diabetic 
cardiomyopathy and echocardiographic assessment 
of LV systolic and diastolic function using ultrasound 
machine (Philips ultrasound,100-
127/220240V~50/60Hz,1010 VA).  
Echocardiography included the conventional 
2D examination and speckle tracking to assess LV 
strain. The study was stored in a digital format with 
patient identity and file number.  
The study was analysed by two experienced 
echocardiographers blinded to the study; the following 
parameters were measured for evaluation of LV 
geometry and function: left ventricular end-diastolic 
dimension (LVEDD), left ventricular end-systolic 
dimension (LVESD), left ventricular ejection fraction 
(LVEF) measured using the modified Simpson's 
method. 
 
Figure 1: Example of assessment of global longitudinal myocardial 
strain (GLS) as provided by the EchoPAC software: apical long-axis 
view, 4-chamber view, and 2-chamber view. In the lower panel, the 
“bull’s eye” plot, using a 17-segment model, provides the value of 
longitudinal strain for each segment of the left ventricle and the 
values of longitudinal strain of apical long-axis (GLPSS-LAX), 4-
chamber (GLPSS A4C), 2-chamber (GLPSS A2C), and the value of 
GLS(GLPSS Avg) 
Quantification of LV mechanics was done 
according to the recommendation using 2D speckle 
tracking echocardiography. A standard 2D ultrasound 
images were obtained. Three waves were analysed 
for longitudinal LV strain in the apical 4 chamber, 
apical 3-chamber and apical 2-chamber views. Cut off 
values of less than -20% were used as indicators of 
systolic dysfunction. 
The regional wall motion abnormality (RWMA) 
was expressed by wall motion score (WMSI) which 
was calculated according to American Society of 
Echocardiography 17-segments model in which 
(normal = 1, hypokinetic = 2, akinetic = 3, dyskinetic = 
4, aneurysmal = 5) Score was calculated by averaging 
the sum of the 17 segments. RWMA was considered 
present if WMSI > 1 [3]. 
Assessment of diastolic function was done 
according to the update of the American society of 
echocardiography imaging and the European 
association of cardiovascular imaging (2015) [4]. 
Mitral inflow was assessed by pulsed-wave Doppler 
from apical four-chamber view during diastole. 
A one or two mm sample volume was placed 
between the tips of mitral flow leaflets during diastole 
and the following parameters were measured: peak E 
velocity (m/s), peak A velocity (m/s), E/A ratio, annular 
É (m/s) by tissue Doppler at the level of mitral annulus 
and the E/É ratio. The E/É ratio > 15 indicates 
elevated left ventricular filling pressure (LVFP), 
whereas E/É < 8 indicates normal left ventricular filling 
pressure [5].
  
The study population was divided into two 
groups based on coronary angiography data: Group I 
included patients with ischemic cardiomyopathy (n = 
48). Group II included patients with diabetic 
cardiomyopathy (DMCMP) (n = 42). 
Ischemia was defined as inadequate blood 
supply (circulation) to a local area due to blockage of 
the blood vessels supplying that area. Stenosis of 
70% in a main coronary artery (> 2.5 mm) in one 
angiographic projection, or 50% in two projections, 
and 50% of the left main coronary artery [6]. 
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 24. Data were summarized 
using mean, standard deviation, median, minimum 
and maximum in quantitative data Comparisons 
between quantitative variables were done using the 
non-parametric Kruskal-Wallis and Mann-Whitney 
tests (Chan, 2003a) [7]. For comparing categorical 
data, Chi-square (2) test was performed. Exact test 
was used instead when the expected frequency is 
less than 5 (Chan, 2003b). P-values less than 0.05 
were considered statistically significant [8].
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Results 
 
The mean age of the whole study group was 
60 ± 10 years, with 18/90 females (20%) and 72/90 
males (80%). The mean age in group I was 63 ± 7 
years and 55 ± 11 years in group II with a statistically 
significant difference, (p = 0.004). Both groups had 
the same gender distribution (9 females in each 
group), (Table 1). 
Table 1: Mean age of study groups 
ICM n = 48 DMCMP n = 42 
Age Mean ± SD Mean ± SD p-value 
63+7 55 +11 0.004 
 
 
There was a statistically significant difference 
between both groups regarding HTN and 
dyslipidemia, both with a higher incidence in group I, 
p ˂ 0.001; p = 0.008 respectively, (Figure 2). 
 
Figure 2: Hypertension and dyslipidemia as risk factors in both 
groups and p-value 
 
There was no statistically significant 
difference between both groups regarding the type 
and duration of DM, wherein group I; 27/48 patients 
(57%) had non-insulin dependent type two diabetes 
mellitus (T2DM) and the mean duration of DM was 
7.7 ± 2.6 years. In group II; 21/42 patients (50%) were 
non-insulin dependent T2DM, and the mean duration 
of DM was 8.3 ± 3.8 years. 
All studied patients were classified according 
to Killip classification; with no statistically significant 
difference between the two groups, (p = 0.131), 
(Table 2). 
Table 2: Killip classification in both groups 
P-value 
 
 
0.131 
DMCMP n = 42(%) ICM n = 48 (%) Killip Classification  
18/42 (43) 15/48 (32) Class II 
21/42 (50) 30 /48 (62) Class III 
3/42 (7) 3/48 (6) Class IV 
 
Out of the studied population, 33 patients 
(36%) were on inotropic and vasopressor support, 
namely dobutamine and norepinephrine, out of whom 
21 patients were in group 12 patients and I in group II. 
 
Comparison of both systolic and diastolic 
 function of both groups 
The left ventricular internal dimensions were 
not statistically significantly different between both 
groups; the mean LVEDD was 6.1 ± 0.9 cm in group I 
and 6.1 ± 1.2 cm in group II with p = 0.926, the mean 
LVESD in group I was 4.8 ± 1 cm and 5 ± 1 cm in 
group II with p = 0.682. 
There was no statistically significant 
difference between the two groups regarding global 
LV systolic function. The mean LVEF was (36 ± 9% in 
group I versus 35 ± 8% in group II, P = 0.497). The 
mean GLS was (-7.7 ± 3% in group I vs -7.9 ± 2.9% in 
group II p = 0.674). The mean WMSI was statistically 
significantly different in both groups, (1.4 ± 0.4 vs 1.1 
± 0.2, respectively, p = 0.005). 
There was no statistically significant 
difference between both groups as regards to LV 
diastolic function except for annular É. The mean E/A 
ratio was (1.5 ± 0.9 in group I vs 1.45 ± 0.8 in group 
II, p = 0.417) while the mean É was statistically 
significant (4.6 ± 1.3 m/s in group I vs 6.1 ± 2.7 m/s in 
group II, p = 0.009), the mean E/É ratio was (15.6 ± 5 
in group I vs 15.73 ± 5 in group II, p = 0.278). 
 
In-hospital survival at 6 months and one 
 year of both groups 
All patients had survived in-hospital course 
with no documented mortality, even those admitted 
with cardiogenic shock. After 6 months, 9 patients 
died in group I and non in group II with a statistically 
significant difference, p = 0.006. After one year 3 
patients died in group ll with no other documented 
mortality in group l and non-statistically significant 
difference, p = 0.077. So, the total mortality was 12 
patients in the whole study population (Figure 3). 
 
Figure 3: Survival rates at 6 months and one year in both study 
groups and p-value 
 
The relation of the mean duration of diabetes 
mellitus to the mortality of patients in both groups was 
not statistically significant at both 6 months, and one 
year (p = 0.955 and 0.837 respectively). 
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Relation of systolic and diastolic function 
 to survival at 6 months and one year in 
 group l 
We studied the relation of different 
echocardiographic values to the mortality after 6 
months and one year in group l; there was a 
statistically significant difference between survived 
and non-survived patients in terms of LV systolic and 
diastolic function, with mean LVEF 40 ± 6% vs 23 ± 
6%; p ˂ 0.001 respectively, and mean GLS of -8 ± 
2.4% vs -4.67 ± 2.6%, p = 0.007 respectively. The 
mean E/A ratio was 1.25 ± 0.91 vs 1.8 ± 0.5, p=0.038 
and the mean E/É was 11.68 ± 7.5 vs 21 ± 3.6, p = 
0.001 respectively in the group of survivors versus 
non-survivors. These findings remained constant after 
one year as there were no new mortalities recorded in 
this group (Figure 4). 
 
Figure 4: Systolic and diastolic echocardiography values at 6 
months and one year in ICM 
 
Relation of systolic and diastolic function 
 to survival at 6 months and one year in 
 group ll 
We studied the relation of echocardiographic 
values to the mortality after 6 months and one year in 
group ll; at 6 months there was no mortality in this 
group, and the mean systolic function for survived 
patients was; LVEF (35 ± 8%), GLS (-7.9 ± 2.9%) 
respectively. The mean diastolic LV function for the 
survived group was: E/A (1.45 ± 0.8), E/É (15.7 ± 5.3) 
respectively. 
 
Figure 5: Systolic and diastolic echocardiography values at 6 
months and one year in DMCMP 
 
However, there was a statistically significant 
difference between survived and non-survived 
patients after one year in LV systolic and diastolic 
function, where the mean LVEF was 35 ± 8% vs 25 ± 
2%, p = 0.014 and the mean GLS was -7.9 ± 2.9% vs 
-5 ± 0.1%, p = 0.032 respectively for the group of 
survivors and non-survivors. The mean E/A ratio in 
survived patients was 1.45 ± 0.8, and in the group of 
non-survivors 3.3 ± 0, p = 0.006. However, the mean 
E/É was non-significantly different in both groups of 
patients (15.73 ± 5.3 vs 15 ± 1, p = 0.873), (Figure 5). 
 
 
Discussion  
 
Diabetes mellitus (DM) is a chronic metabolic 
disorder with steadily increasing prevalence all over 
the world [9].
 
Diabetic cardiomyopathy (DMCMP) [10] 
is a cardiac dysfunction which affects approximately 
12% of diabetic patients, leading to overt heart failure 
and death. However, there is no efficient and specific 
methodology for the diagnosis of diabetic 
cardiomyopathy, possibly because molecular 
mechanisms are not fully explained, and it remains 
asymptomatic for many years [11].
  
Left ventricular systolic function is routinely 
quantified by measuring LVEF [12]. Two-dimensional 
speckle tracking echocardiography in recent years 
has emerged as a method for assessing LV systolic 
function. Global longitudinal strain (GLS), obtained by 
2-dimensional speckle tracking echocardiography is a 
measurement that has previously been demonstrated 
to be of prognostic value, GLS provided incremental 
prognostic information when added to a model 
including conventional echocardiographic parameter 
and clinical predictors [13].
  
In our study, the mean age in group I was 63 
± 7 versus 55 ± 11 years in group II with a statistically 
significant p = 0.004. Diastolic echocardiography 
indices in group I was higher with advanced age 
compared to group II, indicating the effect of age on 
diastolic function. These findings in our study were 
similar to that of Kane et al., (2011) who studied the 
effect of age on diastolic dysfunction. The study 
concluded that age-related progression of diastolic 
dysfunction in the population contributes to the 
pathophysiologic changes which cause severe heart 
failure in these patients [14]. 
In a group, I (57%) had non-insulin 
dependent T2DM, and the mean duration of DM was 
7.7 ± 2.6 years while in group II (50%) were non -
insulin-dependent with a mean duration of diabetes of 
8.3 ± 3.8 years. We compared our study findings with 
that of Zoungas S et al., (2014), who studied the 
effect of mean age at diagnosis of diabetes and the 
duration of the disease which was 7.9 ± 6.4 years. He 
stated that the long duration of diabetes was 
associated with the risk of microvascular events and 
this effect was greater in the younger patients. No 
interaction was observed between diabetes duration, 
age and the risk of macrovascular events or death 
[15].
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In our study we measured both LVEF and 
GLS in both our study groups as a marker of systolic 
function and we compared our results to Sengeløv et 
al., (2015) who stated that speckle tracking 
echocardiography, specifically GLS, is superior to 
conventional echocardiographic parameters, including 
left ventricular ejection fraction, in predicting all-cause 
mortality in patients with heart failure with reduced 
ejection fraction (HFrEF) [13].
  
Senglov et al. also investigated the prognostic 
value of global longitudinal strain (GLS) about the 
patient with HFrEF and concluded that GLS is an 
independent predictor of cause mortality and is a 
superior prognosticator compared to all other 
echocardiographic parameters in predicting mortality 
in these patients [13], [16].
 
 
The finding goes hand in hand with our results 
since the mortality rate was higher in patients with low 
GLS and low LVEF in both our study groups. 
Also, Argulian et al., (2016) stated that the 
GLS is the most reliable method of detecting systolic 
dysfunction and that cut off value of (-20%) is 
considered normal while values less than (-20%) are 
abnormal and indicate systolic dysfunction [16].
 
We 
found that most of our patients had a GLS of less than 
(-15%), which indicated systolic dysfunction. 
Radwan et al., in (2016) assessed the GLS in 
80 patients who had cardiomyopathy and were 
divided into two groups, one with CAD and the other 
without CAD according to angiography. The study 
showed that the GLS measure is a sensitive and 
accurate tool in predicting severe CAD. The study 
used a low cutoff value of GLS -15.6% in which 
patients with GLS less than -15.6% had significant 
obstructive CAD stenosis > 70% [17]. 
In our study, the RWMA was assessed by 
measuring the (WMSI). There was a statistically 
significant difference between both study groups. 
The wall motion score index (WMSI) in group 
I with ICM was higher than that in group II and this 
was explained by the presence of CAD and risk 
factors such as hypertension, dyslipidemia, and 
positive family history of CAD which played a role in 
the occurrence of wall motion abnormalities. In group 
II with DMCMP, the presence of wall motion 
abnormality might be explained by atherosclerotic 
changes which are pronounced in diabetic patients 
and also the development of micro thrombosis. 
The findings in our study go hand in hand with 
Esmaeilzadeh et al. (2013) who studied the 
correlation between WMSI with coronary artery 
lesions. The study stated that a normal LV has a wall 
motion score index of 1 and the index increases as 
wall motion abnormalities increase in severity. The 
study concluded that a WMSI of 1.1-1.9 could predict 
small infarct size, and an index greater than 2.0 
predicts the occurrence of complications and increase 
mortality [18].
 
However, a combined study of LVEF, 
WMSI and GLS proved superiority and accuracy of 
GLS in predicting long term outcome in ischemic 
cardiomyopathy [19]. 
LV diastolic function is assessed by many 
indices, such as the ratio of peak early to late diastolic 
filling velocity E/A ratio and tissue doppler mitral early 
diastolic velocity (E) combined with peak transmittal 
annular early diastolic velocity (É) in order to obtain a 
dimensionless index E/É, which provides a fair 
estimate of LV filling pressure [20], [21].
  
In group l; the mean É was (4.6 ± 1.3 m/s) 
while in group II the mean É was (6.1 ± 2.7 m/s) 
higher than that in group I with a statistically 
significant difference between the two groups, (p 
0.009). However, the E/É ratio in group I was 15.6 ± 5 
compared to a ratio of 15.73 ± 5 in group ll with no 
statistically significant difference between the two 
groups. These findings showed that hypertension and 
CAD in patients with diabetes added to the risk of 
developing LV diastolic dysfunction. The E/E' of > 15 
in patients with DM is associated with subsequent HF 
and increased mortality independent of HTN, CAD, or 
other echocardiographic parameters [22].
 
In our study, the mean E/A ratio for those who 
survived at 6 months was (1.25 ± 0.91 vs 1.8 ± 0.5) 
for non- survived patients in group l, while for group ll 
there was no mortality at 6 months, and the mean E/A 
was 1.45 ± 0.8. The Strong Heart Study follow-up 
(2002) showed that, a transmitral E/A ratio < 0.6 
(pattern of abnormal relaxation) is associated to a 
doubled increase of mortality risk and an E/A ratio > 
1.5 (pattern pseudonormal/restrictive) is associated to 
a threefold increase of cardiac mortality [23].
 
In our study in terms of outcome and 
complication, both groups had survived the in-hospital 
course despite the presence of patients with 
cardiogenic shock. We had nine patients who died in 
group I after 6 months, and three patients died in 
group II after one year. Short term outcome goes in 
hand with Johansson et al., (2016) who found that 
type two diabetes mellitus (T2DM) was shown to be a 
predictor of mortality in both ischemic and non-
ischemic heart failure, although the presence of 
ischemic heart disease (IHD) with T2DM appeared to 
have the worst outcome [24].
 
Our results also were similar to that of Sarma 
et al., (2013) who demonstrated in his study that 
diabetic patients with HF and low LVEF tend to have 
more co-morbidities and worse long- term outcomes 
after hospitalization, specifically increased rates of 
cardiovascular mortality and re-hospitalization after 
discharge, than those without DM, even after 
adjusting for baseline risk factors and medications, 
DM was associated with a (17%) increased risk for 
cardiovascular mortality and hospitalization for HF 
over a median follow-up of 9.9 months [25].
 
 Limitation:  We excluded a rather big sample 
from our final study results as the views were not 
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analysed by speckle tracking software and this was 
due to poor quality of images. The values for the 
strain parameters measured in this study were 
calculated using feature tracking post-processing 
software. This remains a research application and 
lacks the clinical validation to enable its adoption into 
routine clinical practice for the screening of diabetic 
cardiomyopathy. 
In conclusion, the combination of 
cardiomyopathy and diabetes affects LV systolic and 
diastolic function; however; ischemic cardiomyopathy 
and diabetic cardiomyopathy had a similar systolic 
and diastolic function. Ischemic cardiomyopathy is 
associated with worse prognosis compared to 
Diabetic cardiomyopathy. We recommend conducting 
a larger study to evaluate the impact of DM on heart 
failure patients over a long period. Further studies are 
warranted to detect early signs of heart failure in 
diabetic patients to prevent deterioration of LV 
function. 
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